ARA-290 — 5 mg

ARA-290 — 5 mg

ARA-290 is a synthetic peptide derived from erythropoietin (EPO), widely studied in research settings for its selective interaction with tissue-protective and immune-modulating signaling pathways. Researchers examine it for how it influences cellular resilience mechanisms, inflammatory response modulation, and downstream repair-associated markers without activating erythropoiesis or other hematologic pathways linked to full-length EPO.

Key Research Observations on ARA-290

Selective engagement of tissue-protective signaling
Research literature describes ARA-290 as an EPO-derived peptide that selectively activates the innate repair receptor (IRR), a pathway associated with cellular protection and regeneration rather than red blood cell production.

Minimal impact on hematologic markers
Studies note that ARA-290 does not significantly influence hematocrit, hemoglobin levels, or erythropoiesis, differentiating it from native erythropoietin in experimental models.

Investigation of inflammatory modulation pathways
Preclinical research explores how ARA-290 may influence cytokine signaling, immune balance, and inflammatory responses in models of tissue stress or injury.

Interest in cellular repair and neuroprotective research
Academic and experimental studies examine ARA-290 for its downstream effects on nerve signaling pathways, tissue recovery markers, and overall cellular resilience under controlled research conditions.